Notopterygium Incisum Extract Promotes Apoptosis by Preventing the Degradation of BIM in Colorectal Cancer

Abstract

Objective

Colorectal cancer (CRC), a prevalent malignancy worldwide, has prompted extensive research into anticancer drugs. Traditional Chinese medicinal materials offer promising avenues for cancer management due to their diverse pharmacological activities. This study investigated the effects of Notopterygium incisum, a traditional Chinese medicine named Qianghuo (QH), on CRC cells and the underlying mechanism.

Methods

The sulforhodamine B assay and colony formation assay were employed to assess the effect of QH extract on the proliferation of CRC cell lines HCT116 and Caco-2. Propidium iodide (PI) staining was utilized to detect cell cycle progression, and PE Annexin V staining to detect apoptosis. Western blotting was conducted to examine the levels of apoptotic proteins, including B-cell lymphoma 2-interacting mediator of cell death (BIM), B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (BAX) and cleaved caspase-3, as well as BIM stability after treatment with the protein synthesis inhibitor cycloheximide. The expression of BAX was suppressed using lentivirus-mediated shRNA to validate the involvement of the BIM/BAX axis in QH-induced apoptosis. The in vivo effects of QH extract on tumor growth were observed using a xenograft model. Lastly, APC^Min+ mice were used to study the effects of QH extract on primary intestinal tumors.

Results

QH extract exhibited significant in vitro anti-CRC activities evidenced by the inhibition of cell proliferation, perturbation of cell cycle progression, and induction of apoptosis. Mechanistically, QH extract significantly increased the stability of BIM proteins, which undergo rapid degradation under unstressed conditions. Knockdown of BAX, the downstream effector of BIM, significantly rescued QH-induced apoptosis. Furthermore, the in vitro effect of QH extract was recapitulated in vivo. QH extract significantly inhibited the tumor growth of HCT116 xenografts in nude mice and decreased the number of intestinal polyps in the APC^Min+ mice.

Conclusion

QH extract promotes the apoptosis of CRC cells by preventing the degradation of BIM.

References

[1] Huang J, Lucero-Prisno DE 3rd Zhang L, et al.. Updated epidemiology of gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol, 2023, 20(5): 271-287

[2] Azietaku JT, Ma H, Yu XA, et al.. A review of the ethnopharmacology, phytochemistry and pharmacology of Notopterygium incisum. J Ethnopharmacol, 2017, 202: 241-255

[3] Ouyang HF, Wang YQ, Zhao LX, et al.. Research progress and application analysis of chemical constituents, pharmacological effects, and pharmacokinetics of the endangered medicinal material Qianghuo. Zhongyi Yaoli Yu Linchuang, 2023, 14(4): 105-111 (Chinese)

[4] Yang CM, Guo JM, Yao TM. Research Progress on Clinical Application and Pharmacological Activity of Qianghuo (Rhizoma Et Radix Notopterygii). Shiyong Zhongyi Neike Zazhi, 2022, 36(4): 25-28 (Chinese)

[5] O’Connor L, Strasser A, O’Reilly LA, et al.. Bim: a novel member of the Bcl-2 family that promotes apoptosis. Embo J, 1998, 17(2): 384-395

[6] Chen L, Willis SN, Wei A, et al.. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell, 2005, 17(3): 393-403

[7] Mami U, Miyashita T, Shikama Y, et al.. Molecular cloning and characterization of six novel isoforms of human Bim, a member of the proapoptotic Bcl-2 family. FEBS Lett, 2001, 509(1): 135-141

[8] Hübner A, Barrett T, Flavell RA, et al.. Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol Cell, 2008, 30(4): 415-425

[9] Lei K, Davis RJ. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A, 2003, 100(5): 2432-2437

[10] Greenhough A, Wallam CA, Hicks DJ, et al.. The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. Oncogene, 2010, 29(23): 3398-3410

[11] Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc, 2006, 1(3): 1112-1116

[12] Gupta I, Singh K, Varshney NK, et al.. Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System that Regulate Apoptosis. Front Cell Dev Biol, 2018, 6: 11

[13] Czabotar PE, Colman PM, Huang DC. Bax activation by Bim?. Cell Death Differ, 2009, 16(9): 1187-1191

[14] Ma LM, Yang JL. Research progress on chemical constituents and pharmacological activities of Notopterygii Rhizoma et Radix. Zhongcaoyao, 2021, 52(19): 6111-6120 (Chinese)

[15] Guo P, Lang YJ, Zhang GT. Research Progress on Chemical Constituents and Pharmacological Activity of Notopterygii Rhizoma. Zhongchengyao, 2019, 41(10): 2445-2459 (Chinese)

[16] Sionov RV, Vlahopoulos SA, Granot Z. Regulation of Bim in Health and Disease. Oncotarget, 2015, 6(27): 23058-23134

[17] Ley R, Balmanno K, Hadfield K, et al.. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem, 2003, 278(21): 18811-18816

[18] Kim H, Tu HC, Ren D, et al.. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell, 2009, 36(3): 487-499

[19] Zhang J, Huang K, O’Neill KL, et al.. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. Cell Death Dis, 2016, 7(6): e2266

[20] Ley R, Ewings KE, Hadfield K, et al.. Extracellular signal-regulated kinases 1/2 are serum-stimulated “Bim(EL) kinases” that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J Biol Chem, 2004, 279(10): 8837-8847

[21] Moujalled D, Weston R, Anderton H, et al.. Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim. EMBO Rep, 2011, 12(1): 77-83

[22] Puthalakath H, Huang DC, O’Reilly LA, et al.. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell, 1999, 3(3): 287-296

[23] Moustafa-Kamal M, Gamache I, Lu Y, et al.. BimEL is phos phorylated at mitosis by Aurora A and targeted for degradation by βTrCP1. Cell Death Differ, 2013, 20(10): 1393-1403

[24] Gilley R, Lochhead PA, Balmanno K, et al.. CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL. Cell Signal, 2012, 24(1): 170-180

[25] Wan L, Tan M, Yang J, et al.. APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction. Dev Cell, 2014, 29(4): 377-391